BC Platforms provides powerful genomic data management and analysis solutions to address some of the biggest healthcare challenges today by leveraging the convergence of genomics and healthcare information technologies.
The Company's high performing genomic data management platform enables flexible data integration, secure analysis and interpretation of molecular and clinical information.
BC Platforms’ vision is to revolutionize decision making in drug development to bring clinical benefits to patients.
Type | Private | |
Founded | 1997 | |
HQ | Zürich, CH | Map |
Website | bcplatforms.com |
Employees (est.) (Apr 2021) | 70 | (+3%) |
Cybersecurity rating | B | More |
Founding Date | 1997 |
BC Platforms total Funding | $25 m |
BC Platforms latest funding size | $15 m |
Time since last funding | a year ago |
BC Platforms investors | Tesi, Debiopharm Innovation Fund, IQVIA |
BC Platforms has 548 Twitter Followers. The number of followers has increased 0.7% month over month and increased 1.6% quarter over quarter
718
Tweets
518
Following
548
Followers
8
Tweets last 30 days
2.1
Avg. likes per Tweet
100%
Tweets with engagement
When was BC Platforms founded?
BC Platforms was founded in 1997.
Who are BC Platforms key executives?
BC Platforms's key executives are Richard Kivel, Tom Gibbs and Jari Heikkinen.
How many employees does BC Platforms have?
BC Platforms has 70 employees.
Who are BC Platforms competitors?
Competitors of BC Platforms include PHEMI Systems, Verily Life Sciences and Castor EDC.
Where is BC Platforms headquarters?
BC Platforms headquarters is located at Bleicherweg 10, Zürich.
Where are BC Platforms offices?
BC Platforms has offices in Zürich, Boston and Espoo.
How many offices does BC Platforms have?
BC Platforms has 3 offices.
Receive alerts for 300+ data fields across thousands of companies